J&J Medical Connect
UPTRAVI®

(selexipag)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

What is the Recommended Dosing for UPTRAVI Tablets for Pulmonary Arterial Hypertension?

Last Updated: 08/20/2024

important information about uptravi

  • Before you take UPTRAVI, tell your healthcare provider if you have narrowing of the pulmonary veins, a condition called pulmonary veno-occlusive disease.1

summary

UPTRAVI tablets

  • The recommended starting dosage of UPTRAVI tablets is 200 micrograms (mcg).1
    • UPTRAVI is usually taken 2 times each day.
  • Your healthcare provider will slowly increase your dose to find the dose of UPTRAVI that is right for you.
    • If you have side effects, your healthcare provider may tell you to change your dose of UPTRAVI.
  • UPTRAVI can be taken with or without food.1
    • Taking UPTRAVI with food may help you tolerate UPTRAVI better.
  • Swallow UPTRAVI tablets whole.1
    • Do not split, crush or chew UPTRAVI tablets.
  • If you miss a dose of UPTRAVI, take it as soon as you remember. If your next scheduled dose is due within 6 hours, skip the missed dose. Take the next dose at your regular time.1
  • If you miss 3 or more days of UPTRAVI, call your healthcare provider to see if your dose needs to be changed.1
  • If you take too much UPTRAVI, call your healthcare provider or go to the nearest hospital emergency room right away.1

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for UPTRAVI.1

 

References

1 UPTRAVI (selexipag) [Prescribing Information]. Titusville, NJ: Actelion Pharmaceuticals US, Inc, a Janssen Pharmaceutical Company. https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/UPTRAVI-pi.pdf